134 related articles for article (PubMed ID: 3493885)
1. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
Schwartz DE; Weidekamm E; Mimica I; Heizmann P; Portmann R
Chemotherapy; 1987; 33(1):1-8. PubMed ID: 3493885
[TBL] [Abstract][Full Text] [Related]
2. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
Weidekamm E; Schwartz DE; Dubach UC; Weber B
Chemotherapy; 1987; 33(4):259-65. PubMed ID: 3608626
[TBL] [Abstract][Full Text] [Related]
3. Absence of pharmacokinetic interaction between Fansidar and mefloquine.
Schwartz DE; Weidekamm E; Ranalder VB; Dubach VC; Forgo I; Weber B
Trans R Soc Trop Med Hyg; 1986; 80(6):1001-2. PubMed ID: 3496691
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet.
Wang NS; Guo XB; Liu QD; Fu LC; Li GQ; Arnold K
Chemotherapy; 1990; 36(3):177-84. PubMed ID: 2338028
[TBL] [Abstract][Full Text] [Related]
5. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
6. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
7. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man.
Edstein MD
Chemotherapy; 1987; 33(4):229-33. PubMed ID: 3608621
[TBL] [Abstract][Full Text] [Related]
9. Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
Mansor SM; Navaratnam V; Mohamad M; Hussein S; Kumar A; Jamaludin A; Wernsdorfer WH
Br J Clin Pharmacol; 1989 Mar; 27(3):381-6. PubMed ID: 2785812
[TBL] [Abstract][Full Text] [Related]
10. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
11. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
12. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
[TBL] [Abstract][Full Text] [Related]
13. A phase I clinical trial of mefloquine in Brazilian male subjects.
de Souza JM
Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
[TBL] [Abstract][Full Text] [Related]
14. Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
Timm U; Weidekamm E
J Chromatogr; 1982 Jun; 230(1):107-14. PubMed ID: 6980889
[TBL] [Abstract][Full Text] [Related]
15. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Li GQ; Arnold K; Guo XB; Jian HX; Fu LC
Lancet; 1984 Dec; 2(8416):1360-1. PubMed ID: 6150365
[TBL] [Abstract][Full Text] [Related]
16. Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma.
Tin F; Nyunt Hlaing ; Lim MA; Win S; Lasserre R
Trans R Soc Trop Med Hyg; 1987; 81(6):910-2. PubMed ID: 3332509
[TBL] [Abstract][Full Text] [Related]
17. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.
Karbwang J; Bunnag D; Breckenridge AM; Back DJ
Eur J Clin Pharmacol; 1987; 32(2):173-7. PubMed ID: 3495440
[TBL] [Abstract][Full Text] [Related]
19. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
20. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
